Literature DB >> 9031061

The spectrum of extrahepatic manifestations in hepatitis C virus infection.

S J Hadziyannis1.   

Abstract

Infection with the hepatitis C virus affects not only the liver but also non-hepatic tissues and may combine with many unrelated diseases and morbid conditions. A number of extrahepatic manifestations have already been recognized. For some of the extrahepatic disorders their association with HCV infection is well established while for others it remains probable or weak. Here, emphasis is given to the well-established extrahepatic manifestations of mixed cryoglobulinaemia, thyroid abnormalities and lichen planus as well as to the newly recognized association with diabetes mellitus, thrombocytopenia and the antiphospholipid syndrome. Pathogenetic mechanisms of extrahepatic and autoimmune features in HCV infection are still unclear and therapeutic decisions in such conditions are difficult. Data on the efficacy and side-effects of therapy with interferon-alpha and corticosteroids are reviewed and some practical guidelines for treatment are given.

Entities:  

Mesh:

Year:  1997        PMID: 9031061     DOI: 10.1046/j.1365-2893.1997.00120.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  17 in total

1.  Porphyria cutanea tarda and hepatitis G and C virus infection.

Authors:  C Mancini; D Griso; D Rivanera; A Macrì; C Casino; D Lilli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

Review 2.  Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis.

Authors:  Da-Wei Li; Tian-Fei Lu; Xiang-Wei Hua; Hui-Juan Dai; Xiao-Lan Cui; Jian-Jian Zhang; Qiang Xia
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 3.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

Review 4.  Chronic hepatitis C virus infection and post-liver transplantation diabetes mellitus.

Authors:  Yun Ma; Wen-Wei Yan
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

5.  Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.

Authors:  E Zuckerman; G Slobodin; A Kessel; E Sabo; D Yeshurun; K Halas; E Toubi
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

6.  Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia.

Authors:  Eva Zusinaite; Kaja Metskula; Riina Salupere
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

7.  Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.

Authors:  Reem Hamdy Abdellatif Mohammed; Hesham Ibrahim ElMakhzangy; Amira Gamal; Fatma Mekky; Mohammed El Kassas; Nabil Mohammed; Mohammed Abdel Hamid; Gamal Esmat
Journal:  Clin Rheumatol       Date:  2010-04-22       Impact factor: 2.980

8.  Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Authors:  Eli Zuckerman; Aharon Kessel; Gleb Slobodin; Edmond Sabo; Daniel Yeshurun; Elias Toubi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.

Authors:  Diana V Stefanova-Petrova; Anelia H Tzvetanska; Elisaveta J Naumova; Anastasia P Mihailova; Evgenii A Hadjiev; Rumiana P Dikova; Mircho I Vukov; Konstantin G Tchernev
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

10.  Beneficial effect of phlebotomy on hepatitis C virus-associated musculoskeletal manifestations.

Authors:  N Hilzenrat; D Buskila; D Zilberman; E Sikuler
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.